Cargando…
A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)
Patients with cancer are at increased risk of hospitalisation and mortality following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, the SARS-CoV-2 phenotype evolution in patients with cancer since 2020 has not previously been described. We therefore evaluated SARS-...
Ejemplares similares
-
The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer research
por: Fittall, Matthew, et al.
Publicado: (2023) -
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study
por: Lee, Lennard Y.W., et al.
Publicado: (2022) -
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study
por: Lee, Lennard Y W, et al.
Publicado: (2022) -
As COVID-19 cases surge despite mass vaccination, it’s time to focus on the vulnerable
por: Little, Martin, et al.
Publicado: (2021) -
TIGIT-based immunotherapeutics in lung cancer
por: Patel, Akshay J, et al.
Publicado: (2023)